This summary provides an overview of several key developments for
Celanese Corporation (CE). The Q4 2025 earnings reports and calls indicate a
mixed performance against analysts' expectations with both
revenue and earnings lagging behind estimates. Despite disappointing Q4 results, multiple investment firms, including
UBS, JP Morgan, Citi, Evercore ISI, and Mizuho, raised their price targets for CE. However, there were also concerns raised about CEโs ability to manage leverage and their ongoing reliance on increasing prices for their acetyl products. The corporation has made strategic decisions, such as divesting its
Micromaxยฎ business and completing the offering of
1.4 billion USD in senior unsecured notes. Its Michigan Technology Center has also expanded, which is likely to bolster their innovation drive.
Risks include ongoing investigations into potential securities fraud, and a recent inventory destocking disclosure resulted in a 13% fall in share prices.
Celanese Corporation CE News Analytics from Tue, 03 Jun 2025 07:00:00 GMT to Fri, 20 Feb 2026 17:43:07 GMT -
Rating 1
- Innovation 8
- Information 7
- Rumor 2
